IDEXX Laboratories

IDEXX Laboratories, Inc. (Nasdaq: IDXX) is a global leader in pet healthcare innovation, providing diagnostic and software products and services for the veterinary market. Founded in 1983 and headquartered in Westbrook, Maine, IDEXX develops and manufactures products for companion animal veterinary practices, animal production, and water testing.

IDEXX's Companion Animal Group (CAG) is its largest segment, offering in-clinic diagnostic solutions such as blood and urine chemistry, hematology, rapid assays, urinalysis, and other laboratory services. The company's product portfolio includes analyzers, consumables, rapid test kits, veterinary software, and diagnostic imaging systems. IDEXX also provides reference laboratory testing services and offers cloud-based practice management software to support veterinary clinics. Its water testing segment develops products to ensure water quality and safety.

In recent years, IDEXX has focused on innovation to address challenges in veterinary practices. In February 2023, the company published a study revealing opportunities to increase veterinary practice productivity through workflow optimization, technology application, and improved talent management. IDEXX introduced the Practice Productivity Index, a framework to help practices find up to 2,000 additional hours per year. The company has also expanded its diagnostic capabilities, launching a novel Cystatin B Test in 2023 to detect kidney injury in cats and dogs before changes in kidney function occur. IDEXX continues to invest in research and development to enhance its product offerings and maintain its position as a leader in veterinary diagnostics and software solutions.